Skip to content

COVID-19 Information from the front line

The Link:

Fear is the easiest but perhaps the most destructive and power draining emotion surrounding the threat of the current viral pandemic. In my opinion, knowledge may be the best medicine, both for prevention and for personal and family protection. The media and politicians seem to cherry-pick the information they emphasize. Over the weekend a friend sent me a video from an emergency medicine and intensive care doctor at the Weill Cornell Medical Center in New York City. He spoke for about thirty minutes then answered questions for approximately another thirty minutes. I found his information to be actionable, positive, and not pressing or emphasizing fear. If you choose to watch the video, I suggest watching it in its entirety as his question answering is at least as powerful as the information he provides when simply speaking about the COVID-19 virus and how to avoid contracting it.

Sr. David Price, Weill Cornell Medical Center, New York: 3/22/2020
Same thing on youTube:
David R. Price, MD
Research Interests
My research at Cornell is focused on critically ill patients in the intensive care unit. My area of interest is translational, patient centered studies that improve the management and outcomes of these patients. Specifically, I am isolating neutrophils from the blood of critically ill patient to better understand the neutrophil contribution to alternative inflammatory pathways. I am working in the lab of Dr. Augustine Choi while also obtaining my Master’s Degree in Clinical & Translational Investigation from the Weill Cornell Medical College Clinical & Translational Science Center.

Mentors: Augustine MK Choi, MD, Fernando J. Martinez, MD, MS, Ilias Siempos, MD, PhD, Edward Schenck, MD, and Martin T. Wells, PhD

Publications, Talks, and Awards

1. Ma KC, Jones DS, Price DR, Turetz ML. Novel discoveries and advances in management of acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine. 2017, 195:9.
2. Price DR, Mikkelsen ME, Umscheid CA, Armstrong EJ. Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis. Crit Care Med 2015. 44(11):1
3. Hecht T, Price DR. Anticoagulation. ACP smart Medicine. Updated July 16, 2015. doi 10.7326/physpro084.
4. Price D, Radke J, Albertson T. Hypocalcaemia after an occult calcium channel blocker overdose: a case report and literature review. Basic and Clinical Pharmacology and Toxicology. 2014, 114(2):217-21.
5. Price D, Harper R, Henderson M. Progressive cervical myelopathy as presentation of sarcoidosis. Journal of General Internal Medicine. 2013, 28(6):855-6.
6. Price D, Kenyon N, Stollenwerk N. A fresh look at paralytics in the critically ill: real promise and real concern. Annals of Intensive Care. 2012, 2:43.

1. Ma KC, Price DR, Nicholson T, Finkelzstein E, Pabon MA, Nakahira K, Siempos II, Choi AM, Schenck EJ. Plasma TRAIL Levels Correlate With Organ Injury and Predict Organ Failure During Critical Illness. 2017 ATS International Conference. ATS 2017
2. Price DR, Sanders AS, Ma KC, Turetz ML. A Young Healthy Male with Rash and Progressive Respiratory Failure. New York State Thoracic Society Annual Assembly 2017. NYSTS 2017.
3. Price D, Armstrong E, Wettersten N. Neuromuscular Blocking Agents And Critical Illness Polyneuromyopathy: A Systematic Review And Meta-Analysis Of Observational Studies. 2014 ATS International Conference. ATS 2014
4. Price D, Stollenwerk N. Determining Correlation between Inferior Vena Cava Collapsibility Index (IVC-CI) and Central Venous Pressure (CVP) in Hypotensive and Intubated Patients with Central Lines. American College of Physicians Northern California Meeting. Oct 2011 San Jose, CA.
5. Price D, Harper R, Henderson M. Shocking: Progressive Cervical Myelopathy as Presentation of Sarcoidosis. American College of Physicians Northern California Meeting. Nov 2010. San Francisco, CA

1. The Do’s and Don’ts of Direct Oral Anticoagulants. Department of Medicine Grand Rounds. Hospital of the University of Pennsylvania. Jan 2016. Philadelphia, PA.
2. Target specific anticoagulants in nonvalvular atrial fibrillation. Section of Hospital Medicine Faculty Development Series. Hospital of the University of Pennsylvania. Jan 2015. Philadelphia, PA.
3. Evidence Based Medicine Approach to Fluid Overload Assessment. Section of Hospital Medicine Faculty Development Series. Hospital of the University of Pennsylvania. Nov 2013. Philadelphia, PA.
4. A Visceral Response: Effusive-Constrictive Pericarditis. Clinical Grand Rounds. University of California Davis. Apr 2013. Sacramento, CA.

2017 1st Place, Best Research Abstract, New York State Thoracic Society Annual Assembly
2017 1st Place, Best Clinical Abstract, New York State Thoracic Society Annual Assembly
2013 Resident Outstanding Teacher Award, UC Davis Medical Center

Add Your Comment (Get a Gravatar)

Your Name


Your email address will not be published. Required fields are marked *.